Literature DB >> 11705990

The transcriptional co-activators CBP and p300 are activated via phenylephrine through the p42/p44 MAPK cascade.

Rosalind Gusterson1, Bhawanjit Brar, David Faulkes, Antonio Giordano, John Chrivia, David Latchman.   

Abstract

The CBP and p300 co-activators play a key role in many aspects of gene regulation being recruited to the DNA via transcription factors that are targets for specific signaling pathways. It has previously been demonstrated that in neuronal cells the ability of CBP and p300 to activate transcription can be directly stimulated by nerve growth factor or calcium-activated signaling pathways. Here we demonstrate that, in cardiac cells, the activity of CBP and p300 is stimulated by phenylephrine (PE) treatment and that they are required for the activation of atrial naturetic factor (ANF) gene expression by PE. Activation of CBP/p300 by PE involves the p42/p44 MAPK pathway and targets primarily the N terminus of p300 and the C terminus of CBP, which are not homologous to one another. To our knowledge, this is the first report of a specific stimulus modulating the activity of CBP and p300 in cardiac cells and it suggests that these factors play an important role in the hypertrophic effect of PE.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11705990     DOI: 10.1074/jbc.M104626200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

Review 1.  Estrogen action and cytoplasmic signaling pathways. Part II: the role of growth factors and phosphorylation in estrogen signaling.

Authors:  Paul H Driggers; James H Segars
Journal:  Trends Endocrinol Metab       Date:  2002-12       Impact factor: 12.015

2.  Ras signaling requires dynamic properties of Ets1 for phosphorylation-enhanced binding to coactivator CBP.

Authors:  Mary L Nelson; Hyun-Seo Kang; Gregory M Lee; Adam G Blaszczak; Desmond K W Lau; Lawrence P McIntosh; Barbara J Graves
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-13       Impact factor: 11.205

3.  Extracellular signal-regulated kinase 2 interacts with and is negatively regulated by the LIM-only protein FHL2 in cardiomyocytes.

Authors:  Nicole H Purcell; Dina Darwis; Orlando F Bueno; Judith M Müller; Roland Schüle; Jeffery D Molkentin
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

4.  Signaling mediated by the dopamine D2 receptor potentiates circadian regulation by CLOCK:BMAL1.

Authors:  Irene Yujnovsky; Jun Hirayama; Masao Doi; Emiliana Borrelli; Paolo Sassone-Corsi
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-10       Impact factor: 11.205

5.  IQGAP1 regulates ERK1/2 and AKT signalling in the heart and sustains functional remodelling upon pressure overload.

Authors:  Mauro Sbroggiò; Daniela Carnevale; Alessandro Bertero; Giuseppe Cifelli; Emanuele De Blasio; Giada Mascio; Emilio Hirsch; Wadie F Bahou; Emilia Turco; Lorenzo Silengo; Mara Brancaccio; Giuseppe Lembo; Guido Tarone
Journal:  Cardiovasc Res       Date:  2011-04-14       Impact factor: 10.787

Review 6.  Control of regulatory T-cell differentiation and function by T-cell receptor signalling and Foxp3 transcription factor complexes.

Authors:  Masahiro Ono
Journal:  Immunology       Date:  2020-03-09       Impact factor: 7.397

7.  Acetylation of a conserved lysine residue in the ATP binding pocket of p38 augments its kinase activity during hypertrophy of cardiomyocytes.

Authors:  Vinodkumar B Pillai; Nagalingam R Sundaresan; Sadhana A Samant; Don Wolfgeher; Chinmay M Trivedi; Mahesh P Gupta
Journal:  Mol Cell Biol       Date:  2011-03-28       Impact factor: 4.272

8.  MicroRNA-335-5p and -3p synergize to inhibit estrogen receptor alpha expression and promote tamoxifen resistance.

Authors:  Elizabeth C Martin; Adrienne K Conger; Thomas J Yan; Van T Hoang; David F B Miller; Aaron Buechlein; Douglas B Rusch; Kenneth P Nephew; Bridgette M Collins-Burow; Matthew E Burow
Journal:  FEBS Lett       Date:  2017-01-12       Impact factor: 4.124

9.  Quantitative control of adaptive cardiac hypertrophy by acetyltransferase p300.

Authors:  Jian Qin Wei; Lina A Shehadeh; James M Mitrani; Monica Pessanha; Tatiana I Slepak; Keith A Webster; Nanette H Bishopric
Journal:  Circulation       Date:  2008-08-12       Impact factor: 29.690

10.  Upstream stimulatory factor 2 and hypoxia-inducible factor 2α (HIF2α) cooperatively activate HIF2 target genes during hypoxia.

Authors:  Matthew R Pawlus; Liyi Wang; Katie Ware; Cheng-Jun Hu
Journal:  Mol Cell Biol       Date:  2012-09-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.